Effects of Physical Use Characteristics During Academic Education on Musculoskeletal Function and Body Awareness in University Students From Different Academic Departments

August 4, 2026 updated by: Ezgi Türkmen, Health Institutes of Turkey
Aim of the study is to compare the levels of spinal stabilization, posture, deep neck flexor muscle endurance, and body awareness of physiotherapy and rehabilitation students and architecture students, whose academic training processes and professional practices are different but intensive, and who possess different physical usage characteristics in these processes, and to reveal the effects of professional training content on the musculoskeletal system.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Detailed Description

The aim of this study is to compare the levels of spinal stabilization, posture, deep neck flexor muscle endurance, and body awareness of physiotherapy and rehabilitation students and architecture students, whose academic training processes and professional practices are different but intensive, and who possess different physical usage characteristics in these processes, and to reveal the effects of professional training content on the musculoskeletal system. The study plans to include volunteer students studying in the 2nd year and above in both the physiotherapy and rehabilitation and architecture departments. This research study is designed as an observational and cross sectional evaluation study.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Physiotherapy and Rehabilitation Department Students & Architecture Department Students

Description

Inclusion Criteria:

  • Being a university student aged 18-25.
  • Being a second-year or higher student in the Physiotherapy and Rehabilitation Department (n=150).
  • Being a second-year or higher student in the Architecture Department (n=150).
  • Having a daily screen time (computer, tablet, mobile phone) of ≥ 3 hours.
  • Agreeing to participate in the study voluntarily.

Exclusion Criteria:

  • Having a diagnosis of surgery or serious injury in the cervical, thoracic, or lumbar region within the last 6 months.
  • Individuals with diagnosed musculoskeletal, neurological, or vestibular system pathologies.
  • Individuals with orthopedic deformities that may affect posture (e.g., scoliosis >20° Cobb angle).
  • Professional athletes or individuals who regularly engage in strength training.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Group I
Physiotherapy and Rehabilitation Department Students
Group II
Architecture Department Students

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Multifidus Muscle Stabilization Assessment
Time Frame: Baseline
A Biofeedback Stabilizer pressure feedback device will be used to determine the stabilization and activation value of the multifidus muscle. Prior to the test, all participants will be taught the abdominal hallowing maneuver. While participants lie supine, the stabilizer device will be placed in the lumbar region. The Biofeedback device will be set to 70 mmHg, and the participant will be asked to perform the abdominal hallowing maneuver without moving the spine and pelvis, maintaining the contraction for at least 10 seconds.
Baseline
New York Posture Rating Chart
Time Frame: Baseline
This assessment will score postural changes in 13 different areas of the body. A score of 5 points will be given for correct postural structure, 3 points for moderate abnormalities, and 1 point for severe abnormalities. A score between 13 and 65 will be obtained on the scale. A score of 45 and above will be classified as "Very Good," 40-44 as "Good," 30-39 as "Moderate," 20-29 as "Poor," and 19 and below as "Poor" posture.
Baseline
Deep Neck Flexor Endurance Test
Time Frame: Baseline
This test will be used to assess deep flexor muscle endurance in the cervical region. The test will be performed in a supine hook position. The participant's hands will be placed loosely on their abdomen. The participant will be asked to pull their chin inward (chin tuck) and, while maintaining this position, lift their head off the bed (approximately 2.5 cm). They will be asked to maintain this position for as long as possible without breaking it, and the time spent in this position will be recorded in seconds.
Baseline
Body Awareness Questionnaire (BAQ)
Time Frame: Baseline
BAQ is an 18-item self-report scale designed to measure how attentive you are to normal, non-emotional internal bodily processes. It evaluates your sensitivity to everyday bodily cycles (like sleep and hunger), ability to detect subtle changes, and capacity to anticipate physical reactions. Typically takes about 3 to 5 minutes. Items are generally rated on a 1 to 7 scale, with higher total scores indicating greater perceived conNdence and accuracy in monitoring your physical state over time.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Health Institutes of Turkey

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
August 4, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
September 1, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
September 1, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
July 28, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 28, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
July 31, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
August 5, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 4, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
July 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • ETurkmen0526

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings